The goal of this randomized, double-blind crossover clinical trial in 50 healthy volunteers sensitive to acidic foods was to evaluate whether Ester-C® calcium ascorbate causes fewer epigastric adverse effects than are produced by regular ascorbic acid (AA). Volunteers were randomly separated into 2 groups of 25. The study comprised an observation period of 9 days (phase 1 medication for 3 consecutive days, washout phase for 3 consecutive days, phase 2 medication for 3 consecutive days). Participants took 1000 mg vitamin C as Ester-C during phase 1 of the study followed by 1000 mg of vitamin C as AA during phase 2, or vice versa. During the course of the study, 3 examinations for the evaluation of epigastric adverse effects were performed (on days 0, 3, and 9). Participants used a diary to record epigastric adverse effects on a daily basis. In total, 28 (56%) of 50 participants reported 88 epigastric adverse effects of mild to moderate intensity. Of these 88 adverse effects, 33 (37.5%) occurred after intake of Ester-C and 55 (62.5%) were noted after intake of AA. The tolerability of Ester-C was rated “very good” by 72% of participants, whereas AA was rated “very good” by only 54%. This difference is statistically significant (P < .05). Investigators concluded that Ester-C compared with AA caused significantly fewer epigastric adverse effects in participants sensitive to acidic foods and that Ester-C is much better tolerated.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Weber P. Vitamin C. In: Biesalski H-K, Köhrle J, Schürmann K, eds.Vitamine, Spurenelemente und Mineralstoffe. Stuttgart, New York: Thieme Verlag; 2002: 57–69.
Hemila H. Vitamin C intake and susceptibility to the common cold.Br J Nutr. 1997; 77: 59–72.
Hemila H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress.Int J Sports Med. 1996; 17: 379–383.
Hemila H. Vitamin C and the common cold.Br J Nutr. 1992; 67: 3–16.
Hemila H, Herman ZS. Vitamin C and the common cold: a retrospective analysis of Chalmers’ review.J Am Coll Nutr. 1995; 14: 116–123.
Audera C, Patulny R, Sander B, Douglas R. Mega-dose vitamin C in treatment of the common cold: a randomized controlled trial.Med J Aust. 2001; 175: 359–362.
Van Straten M, Josling P. Preventing the common cold with a vitamin C supplement: a doubleblind, placebo-controlled survey.Adv Ther. 2002; 19: 151–159.
Hendler SS, Rorvik D, eds. Vitamin C. In:PDR for Nutritional Supplements. Montvale: Medical Economics Company; 2001: 486–498.
Wright JV, Suen RM, Kirk FR. Comparative studies of “Ester C” versus L-ascorbic acid.Int Clin Nutr Rev. 1990; 10: 7–10.
Bush MJ, Verlangieri AJ. An acute study on the relative GI absorption of a novel form of calcium ascorbate.Res Commun Chem Pathol Pharmacol. 1987; 57: 137–140.
Verlangieri AJ, Fay MJ, Bannon AW. Comparison of the anti-scorbutic activity of L-ascorbic acid and Ester C® in the non-ascorbate synthesizing osteogenic disorder shionogi (ODS) rat.Life Sci. 1991; 48: 2275–2281.
Fay MJ, Verlangieri AJ. Stimulatory action of calcium L-threonate on ascorbic acid uptake by a human T-lymphoma cell line.Life Sci. 1991; 49: 1377–1381.
Fay MJ, Bush MJ, Verlangieri AJ. Effect of aldonic acids on the uptake of ascorbic acid by 3T3 mouse fibroblasts and human T lymphoma cells.Gen Pharm. 1994; 25: 1465–1469.
Rights and permissions
About this article
Cite this article
Gruenwald, J., Graubaum, HJ., Busch, R. et al. Safety and tolerance of Ester-C® compared with regular ascorbic acid. Adv Therapy 23, 171–178 (2006). https://doi.org/10.1007/BF02850358
- vitamin C
- acidic food